Stockhead’s Fraser Palamara sits down with Island Pharmaceuticals (ASX:ILA)  CEO and managing director David Foster to get the short end of the long story on the company’s latest news.

The dengue vaccine market is on track for robust growth, with increasing global awareness, governmental support, and ...

Progression to the phase 2b cohort follows recommendation of the Safety Review Committee (SRC) after it reviewed positive ...

Island Pharmaceuticals Ltd (ASX:ILA) has successfully enrolled its first subjects for a Phase 2b clinical trial to test the ...

Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...